Zobrazeno 1 - 10
of 188
pro vyhledávání: '"Robert W Holloway"'
Autor:
Ana Oaknin, Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Andrew Dean, Nicoletta Colombo, Johanne I. Weberpals, Andrew R. Clamp, Giovanni Scambia, Alexandra Leary, Robert W. Holloway, Margarita Amenedo Gancedo, Peter C. Fong, Jeffrey C. Goh, David M. O’Malley, Deborah K. Armstrong, Susana Banerjee, Jesus García‐Donas, Elizabeth M. Swisher, Terri Cameron, Lara Maloney, Sandra Goble, Jonathan A. Ledermann, Robert L. Coleman
Publikováno v:
Cancer Medicine, Vol 10, Iss 20, Pp 7162-7173 (2021)
Abstract Background The efficacy and safety of rucaparib maintenance treatment in ARIEL3 were evaluated in subgroups based on best response to most recent platinum‐based chemotherapy and baseline disease. Methods Patients were randomized 2:1 to rec
Externí odkaz:
https://doaj.org/article/2cbcf9c399a94021b6832bbcf96e807d
Autor:
Nnamdi I. Gwacham, Madhavi Manyam, Christine K. Fitzsimmons, Karolina A. Kilowski, David Varnagy, Tomer Z. Karas, Robert W. Holloway
Publikováno v:
Gynecologic Oncology Reports, Vol 40, Iss , Pp 100946- (2022)
Intravenous leiomyomatosis (IVL) is an uncommon variant of leiomyoma characterized by intravascular proliferation of a histologically benign smooth muscle tumor extending beyond the uterus into the distant great vessels. Leiomyomatosis may reach the
Externí odkaz:
https://doaj.org/article/a3357e982d9e488f976b8419663fe474
Publikováno v:
Gynecologic Oncology Reports, Vol 31, Iss , Pp - (2020)
Background: Non-gestational choriocarcinomas represent a small subset of germ cell tumors. The majority of non-gestational choriocarcinomas arise from the gynecologic tract. In rare cases, they can originate from other sites, and very few such cases
Externí odkaz:
https://doaj.org/article/a2b35045a51b476bb8f0d6988e819ead
Publikováno v:
Gynecologic Oncology Reports, Vol 25, Iss , Pp 70-73 (2018)
Ovarian Sertoli-Leydig cell tumors (SLCT) represent
Externí odkaz:
https://doaj.org/article/b6aca21cb8b14b4db6eeb67ae729a9c8
Publikováno v:
OncoTargets and Therapy. 15:853-866
Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer. The gold standard therapeutic approach is a combination of surgery plus chemotherapy. Unfortunately, 80% of patients with EOC suffer recurrence within 2-years and the overall resp
Autor:
Sarfraz Ahmad, Robert W. Holloway, Madhavi Manyam, Amanda J. Stephens, Jessica A. Kennard, James E. Kendrick, Jane LeBlanc
Publikováno v:
Gynecologic Oncology. 163:481-489
Objective Our objective was to assess safety and adverse events associated with intraperitoneal Olvi-Vec virotherapy in patients with platinum-resistant or refractory ovarian cancer (PRROC). Secondary objectives included objective response rate (ORR)
Autor:
Sarfraz Ahmad, Christine K. Fitzsimmons, Jessica A. Kennard, James E. Kendrick, Nathalie D. McKenzie, Robert W. Holloway, Madhavi Manyam, Amanda J. Stephens, Julie Pepe
Publikováno v:
Annals of Surgical Oncology. 29:2006-2013
PURPOSE Minimally invasive radical hysterectomy has been associated with increased recurrence of disease and worse survival compared with open radical hysterectomy for early-stage cervical cancer. We evaluated patterns of recurrence and histopatholog
Publikováno v:
Gynecologic Oncology. 162:809-815
Background Approach to the management of early stage cervical cancers with tumor size >2 cm in women who desire fertility preservation has been fraught with controversy. Fertility sparing surgery for FIGO 2018 stage IB cancers has been validated most
Autor:
Robert W. Holloway, Tien Anh N. Tran
Publikováno v:
International Journal of Gynecological Pathology. 40:369-375
Although histiocytic lesions of the fallopian tube are relatively rare compared to their epithelial counterparts, there exists a spectrum of histiocytic lesions involving the fallopian tube that are described under different terminologies dependent o
Autor:
K. Peng, Stacy A. Smrz, Monica Hagan Vetter, Alexander B. Olawaiye, Paola A. Gehrig, W.H. Gotlieb, Keitaro Matsuo, Laura L. Holman, Shitanshu Uppal, Kathleen G Essel, Kristin Bixel, Laurie L. Brunette, M.P. Cisa, A. Stuart Staley, Stephen L. Rose, B.F. Lees, Ester Goldfeld, Robert W. Holloway, Brittany A. Davidson, Katherine L. Tucker
Publikováno v:
Gynecologic Oncology. 159:354-358
The objective of this study was to assess the rate of discordance between clinical and pathologic tumor size for women with stage IB1 cervical cancer (FIGO 2009 criteria), assess risk factors for discordance, and determine the impact of discordance o